The Key Parainfluenza Virus Infection Companies in the market include – Ansun Biopharma, AlloVir, MedImmune LLC, and others. DelveInsight’s “Parainfluenza…
Read More
Postoperative Pain Management Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Taiwan Liposome Company, Teikoku Pharma USA, Durect, Pfizer, Vivozon, Salvat Lab
The Key Postoperative Pain Management Companies in the market include – Ocular Therapeutix, Heron Therapeutics, Avenue Therapeutics, Taiwan Liposome Company…
Read More
Cerebral Aneurysm Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Edge Therapeutics, NoNO Inc., BIT Pharma GmbH
The Key Cerebral Aneurysm Companies in the markret include – Edge Therapeutics Inc, NoNO Inc., BIT Pharma GmbH, and others.…
Read More
Dry AMD Market Expected to rise, 2034 | Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics
Dry AMD Market Expected to rise by 2034, DelveInsight The Dry AMD market growth is driven by factors like increase…
Read More
Paid Clinical Trials at Top Research of West Florida: Safe & Regulated Medical Studies for Tampa Residents
Top Research of West Florida, a clinical research facility in Tampa Bay, is conducting paid clinical trials for residents in…
Read More
Cell And Gene Therapy For Multiple Myeloma Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, Regeneron
The Key Cell And Gene Therapy For Multiple Myeloma Companies in the marlket include – Johnson & Johnson Innovative Medicine,…
Read More
Onychomycosis Market Size in the US was ~USD 760 million in 2023, is expected to grow at a significant CAGR by 2034, estimates DelveInsight
DelveInsight’s “Oncychomycosis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Oncychomycosis, historical and forecasted epidemiology…
Read More
Lyme Disease Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Lyme Disease Pipeline Insight” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Lyme Disease (LD)…
Read More
Hospital-acquired and Ventilator-associated Bacterial Pneumonia Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2034, estimates DelveInsight
DelveInsight’s “Hospital-acquired and Ventilator-associated Bacterial Pneumonia Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of…
Read More
Hepatitis B Virus Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Hepatitis B Virus (HBV) Infection Pipeline Insight” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in…
Read More
Liposarcoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Liposarcoma Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Liposarcoma pipeline landscape.…
Read More
BRAF Mutated Non-small Cell Lung Cancer Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics
The Key BRAF Mutated Non-small Cell Lung Cancer Companies in the market include – AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck…
Read More
Idiopathic Inflammatory Myositis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Idiopathic Pulmonary Fibrosis Pipeline Insight” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary…
Read More
Age-related Macular Degeneration Drugs Market to Hit USD 17.37 Billion by 2029 with 10.7% CAGR
Key players in the Age-Related Macular Degeneration (AMD) drugs market include Regeneron Pharmaceuticals Inc. (US), Bayer AG (Germany), F. Hoffmann-La…
Read More
Clostridium Difficile Infections Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Merck & Co, Tillotts Pharma, Astellas Pharma, Pfizer, Vedanta Biosciences, MGB Biopharma
The Key Clostridium Difficile Infections Companies in the market include – Merck & Co, Tillotts Pharma, Astellas Pharma, Pfizer, Vedanta…
Read More
Translate »
